Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.01598
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives

Clinical Cancer Research
Cancer ResearchOncology
2011English

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer

Oncotarget
Oncology
2017English

MA11.05 Indoleamine 2,3-Dioxygenase Expression in Non-Small-Cell Lung Cancer: Analyses of Prevalence, Clinical Correlations and Prognostic Impact

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Advances in Indoleamine 2,3-Dioxygenase 1 Medicinal Chemistry

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2017English

Aryl Hydrocarbon Receptor Signaling Mediates Expression of Indoleamine 2,3-Dioxygenase

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2008English

Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth With Ethyl Pyruvate

Cancer Research
Cancer ResearchOncology
2010English

Indole Peroxygenase Activity of Indoleamine 2,3-Dioxygenase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Critical Role of Indoleamine 2,3-Dioxygenase in Tumor Resistance to Repeated Treatments With Targeted IFN

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy